* Conmed Corp CNMD.N CNMD.K is expected to show a rise
in
quarterly revenue when it reports results on July 31 for the
period ending June 30 2024
* The Largo Florida-based company is expected to report a
4.6% increase in revenue to $332.325 million from $317.65
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Conmed Corp is for
earnings of
91 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Conmed Corp
is
$88.00, above its last closing price of $70.08.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 0.74 0.74 0.79 Beat 7
Dec. 31 2024 1.11 1.11 1.06 Missed -4.5
Sep. 30 2023 0.83 0.83 0.90 Beat 8.4
Jun. 30 2023 0.79 0.79 0.83 Beat 4.5
Mar. 0.60 0.60 0.66 Beat 10.3
31 2023
Dec. 31 2022 0.89 0.90 0.42 Missed -53.5
Sep. 30 2022 0.75 0.75 0.77 Beat 2.4
Jun. 30 2022 0.74 0.75 0.76 Beat 1.8
This summary was machine generated July 29 at 20:56 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)